Position history for RTW INVESTMENTS, LP's holdings in PROTAGONIST THERAPEUTICS INC
RTW INVESTMENTS, LP holds 5.1M shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $441.9M as of 2025-Q4. The position was decreased (-12.1% shares). PTGX represents 4.4% of RTW INVESTMENTS, LP's portfolio.
Current Value
$441.9M
Current Shares
5.1M
Total Value Change
+$258.7M
Total Shares Change
-227,351
Other major holders of PTGX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, CAPITAL FUND MANAGEMENT S.A.
Decreased |
| 5.1M |
-12.1% |
| $441.9M |
| 4.4% |
| $87.26 |
0 |
| 2025-Q3 | Unchanged | 5.8M | 0.0% | $382.4M | 4.7% | $65.14 | 0 |
| 2025-Q2 | Increased | 5.8M | +0.6% | $318.1M | 4.5% | $55.69 | 57 |
| 2025-Q1 | Increased | 5.7M | +4.0% | $276.6M | 4.2% | $48.88 | 59 |
| 2024-Q4 | Increased | 5.5M | +1.3% | $212.2M | 3.2% | $38.51 | 57 |
| 2024-Q3 | Increased | 5.4M | +2.6% | $244.2M | 3.5% | $44.56 | 58 |
| 2024-Q2 | Decreased | 5.3M | -0.6% | $183.2M | 2.8% | $34.65 | 0 |